Colorectal cancer now has the most real-world data, but Phesi warns clinical trials are lagging behind.

WHAM’s Innovator’s Circle unites top funds to address the women’s health investment gap.

Trump’s “most-favoured nation” drug pricing plan shakes pharma markets, sparking losses for US and EU firms.

The initiative is set to revolutionise healthcare delivery and agricultural exports in low- and middle-income countries.

Gallman takes on the role of EVP, General Counsel and Chief Policy Officer, following Sandra Leung’s retirement after 33 years.

From new scientific data-sharing initiatives to US drug tariffs, May brought a range of major news to the pharma landscape.

Eli Lilly joins forces with Alchemab in a deal worth $415m, expanding its neuroscience pipeline with a novel candidate.

Generation Gold Standard is a universal vaccine platform targeting influenza, coronaviruses and future pandemics.